Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 11-20 of 21

Page
per page
  1. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  2. AR-A014418
    A3184 AR-A014418
     2 Citation
    Target: GSK-3
    Summary: GSK3β inhibitor, ATP-competitive and selective
      insoluble in EtOH; insoluble in H2O; ≥15.4 mg/mL
  3. TCS 2002
    B5486 TCS 2002
    Summary: GSK -3β inhibitor, potent
      <33.84 mg/mL
  4. BIO-acetoxime
    B5488 BIO-acetoxime
    Summary: GSK-3α/β inhibitor
      insoluble in H2O; insoluble in EtOH; ≥12.75 mg/mL
  5. TC-G 24
    B5561 TC-G 24
    Summary: GSK-3β inhibitor
      insoluble in DMSO
  6. CHIR 99021 trihydrochloride
    B5779 CHIR 99021 trihydrochloride
    Summary: A glycogen synthase kinase 3 (GSK-3) inhibitor
      insoluble in EtOH; ≥21.87 mg/mL
  7. IM-12
    B4793 IM-12
    Summary: GSK-3β inhibitor, potent
      insoluble in H2O; ≥18.85 mg/mL
  8. A 1070722
    B7665 A 1070722
    Summary: GSK-3 inhibitor
      <36.23 mg/mL
  9. TCS 183
    B5277 TCS 183
    Summary: competitive inhibitor of GSK-3β (Ser9) phosphorylation
      Soluble to 1 mg/mL
  10. TCS 184
    B5290 TCS 184
    Summary: Scrambled control peptide for use with TCS 183
      Soluble to 1 mg/mL

Items 11-20 of 21

Page
per page